Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice

Masato Asanuma, H. Hirata, J. L. Cadet

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

6-Hydroxydopamine is a neurotoxin that produces degeneration of the nigrostriatal dopaminergic pathway in rodents. Its toxicity is thought to involve the generation of superoxide anion secondary to its autoxidation. To examine the effects of the overexpression of Cu,Zn-superoxide dismutase activity on 6-hydroxydopamine-induced dopaminergic neuronal damage, we have measured the effects of 6-hydroxydopamine on striatal and nigral dopamine transporters and nigral tyrosine hydroxylase-immunoreactive neurons in Cu,Zn- superoxide dismutase transgenic mice. Intracerebroventricular injection of 6- hydroxydopamine (50 μg) in non-transgenic mice produced reductions in the size of striatal area and an enlargement of the cerebral ventricle on both sides of the brains of mice killed two weeks after the injection. In addition, 6-hydroxydopamine caused marked decreases in striatal and nigral [125I]RTI-121-labelled dopamine transporters not only on the injected side but also on the non-injected side of non-transgenic mice; this was associated with decreased cell number and size of tyrosine hydroxylase-immunoreactive dopamine neurons in the substantia nigra pars compacta on both sides in these mice. In contrast, superoxide dismutase transgenic mice were protected against these neurotoxic effects of 6-hydroxydopamine, with the homozygous transgenic mice showing almost complete protection. These results provide further support for a role of superoxide anion in the toxic effects of 6- hydroxydopamine. They also provide further evidence that reactive oxygen species may be the main determining factors in the neurodegenerative effects of catecholamines.

Original languageEnglish
Pages (from-to)907-917
Number of pages11
JournalNeuroscience
Volume85
Issue number3
DOIs
Publication statusPublished - Apr 24 1998
Externally publishedYes

Fingerprint

Oxidopamine
Transgenic Mice
Superoxide Dismutase
Corpus Striatum
Substantia Nigra
Dopamine Plasma Membrane Transport Proteins
Tyrosine 3-Monooxygenase
Superoxides
Cerebral Ventricles
Injections
Poisons
Dopaminergic Neurons
Neurotoxins
Cell Size
Catecholamines
Rodentia
Reactive Oxygen Species
Cell Count
Neurons
Brain

Keywords

  • 6-hydroxydopamine
  • Dopamine transporter
  • Parkinson's disease
  • Superoxide anion
  • Superoxide dismutase
  • Transgenic mice

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. / Asanuma, Masato; Hirata, H.; Cadet, J. L.

In: Neuroscience, Vol. 85, No. 3, 24.04.1998, p. 907-917.

Research output: Contribution to journalArticle

@article{85e428df36da42218f081f74ef16af0c,
title = "Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice",
abstract = "6-Hydroxydopamine is a neurotoxin that produces degeneration of the nigrostriatal dopaminergic pathway in rodents. Its toxicity is thought to involve the generation of superoxide anion secondary to its autoxidation. To examine the effects of the overexpression of Cu,Zn-superoxide dismutase activity on 6-hydroxydopamine-induced dopaminergic neuronal damage, we have measured the effects of 6-hydroxydopamine on striatal and nigral dopamine transporters and nigral tyrosine hydroxylase-immunoreactive neurons in Cu,Zn- superoxide dismutase transgenic mice. Intracerebroventricular injection of 6- hydroxydopamine (50 μg) in non-transgenic mice produced reductions in the size of striatal area and an enlargement of the cerebral ventricle on both sides of the brains of mice killed two weeks after the injection. In addition, 6-hydroxydopamine caused marked decreases in striatal and nigral [125I]RTI-121-labelled dopamine transporters not only on the injected side but also on the non-injected side of non-transgenic mice; this was associated with decreased cell number and size of tyrosine hydroxylase-immunoreactive dopamine neurons in the substantia nigra pars compacta on both sides in these mice. In contrast, superoxide dismutase transgenic mice were protected against these neurotoxic effects of 6-hydroxydopamine, with the homozygous transgenic mice showing almost complete protection. These results provide further support for a role of superoxide anion in the toxic effects of 6- hydroxydopamine. They also provide further evidence that reactive oxygen species may be the main determining factors in the neurodegenerative effects of catecholamines.",
keywords = "6-hydroxydopamine, Dopamine transporter, Parkinson's disease, Superoxide anion, Superoxide dismutase, Transgenic mice",
author = "Masato Asanuma and H. Hirata and Cadet, {J. L.}",
year = "1998",
month = "4",
day = "24",
doi = "10.1016/S0306-4522(97)00665-9",
language = "English",
volume = "85",
pages = "907--917",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice

AU - Asanuma, Masato

AU - Hirata, H.

AU - Cadet, J. L.

PY - 1998/4/24

Y1 - 1998/4/24

N2 - 6-Hydroxydopamine is a neurotoxin that produces degeneration of the nigrostriatal dopaminergic pathway in rodents. Its toxicity is thought to involve the generation of superoxide anion secondary to its autoxidation. To examine the effects of the overexpression of Cu,Zn-superoxide dismutase activity on 6-hydroxydopamine-induced dopaminergic neuronal damage, we have measured the effects of 6-hydroxydopamine on striatal and nigral dopamine transporters and nigral tyrosine hydroxylase-immunoreactive neurons in Cu,Zn- superoxide dismutase transgenic mice. Intracerebroventricular injection of 6- hydroxydopamine (50 μg) in non-transgenic mice produced reductions in the size of striatal area and an enlargement of the cerebral ventricle on both sides of the brains of mice killed two weeks after the injection. In addition, 6-hydroxydopamine caused marked decreases in striatal and nigral [125I]RTI-121-labelled dopamine transporters not only on the injected side but also on the non-injected side of non-transgenic mice; this was associated with decreased cell number and size of tyrosine hydroxylase-immunoreactive dopamine neurons in the substantia nigra pars compacta on both sides in these mice. In contrast, superoxide dismutase transgenic mice were protected against these neurotoxic effects of 6-hydroxydopamine, with the homozygous transgenic mice showing almost complete protection. These results provide further support for a role of superoxide anion in the toxic effects of 6- hydroxydopamine. They also provide further evidence that reactive oxygen species may be the main determining factors in the neurodegenerative effects of catecholamines.

AB - 6-Hydroxydopamine is a neurotoxin that produces degeneration of the nigrostriatal dopaminergic pathway in rodents. Its toxicity is thought to involve the generation of superoxide anion secondary to its autoxidation. To examine the effects of the overexpression of Cu,Zn-superoxide dismutase activity on 6-hydroxydopamine-induced dopaminergic neuronal damage, we have measured the effects of 6-hydroxydopamine on striatal and nigral dopamine transporters and nigral tyrosine hydroxylase-immunoreactive neurons in Cu,Zn- superoxide dismutase transgenic mice. Intracerebroventricular injection of 6- hydroxydopamine (50 μg) in non-transgenic mice produced reductions in the size of striatal area and an enlargement of the cerebral ventricle on both sides of the brains of mice killed two weeks after the injection. In addition, 6-hydroxydopamine caused marked decreases in striatal and nigral [125I]RTI-121-labelled dopamine transporters not only on the injected side but also on the non-injected side of non-transgenic mice; this was associated with decreased cell number and size of tyrosine hydroxylase-immunoreactive dopamine neurons in the substantia nigra pars compacta on both sides in these mice. In contrast, superoxide dismutase transgenic mice were protected against these neurotoxic effects of 6-hydroxydopamine, with the homozygous transgenic mice showing almost complete protection. These results provide further support for a role of superoxide anion in the toxic effects of 6- hydroxydopamine. They also provide further evidence that reactive oxygen species may be the main determining factors in the neurodegenerative effects of catecholamines.

KW - 6-hydroxydopamine

KW - Dopamine transporter

KW - Parkinson's disease

KW - Superoxide anion

KW - Superoxide dismutase

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0031946038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031946038&partnerID=8YFLogxK

U2 - 10.1016/S0306-4522(97)00665-9

DO - 10.1016/S0306-4522(97)00665-9

M3 - Article

VL - 85

SP - 907

EP - 917

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 3

ER -